Search for "initiation" in Full Text gives 149 result(s) in Beilstein Journal of Organic Chemistry.
Beilstein J. Org. Chem. 2021, 17, 1641–1688, doi:10.3762/bjoc.17.116
Graphical Abstract
Figure 1: Structure of DNA and PNA.
Figure 2: PNA binding modes: (A) PNA–dsDNA 1:1 triplex; (B) PNA–DNA–PNA strand-invasion triplex; (C) the Hoog...
Figure 3: Structure of P-form PNA–DNA–PNA triplex from reference [41]. (A) view in the major groove and (B) view ...
Figure 4: Structures of backbone-modified PNA.
Figure 5: Structures of PNA having α- and γ-substituted backbones.
Figure 6: Structures of modified nucleobases in PNA to improve Hoogsteen hydrogen bonding to guanine and aden...
Figure 7: Proposed hydrogen bonding schemes for modified PNA nucleobases designed to recognize pyrimidines or...
Figure 8: Modified nucleobases to modulate Watson–Crick base pairing and chemically reactive crosslinking PNA...
Figure 9: Examples of triplets formed by Janus-wedge PNA nucleobases (blue). R1 denotes DNA, RNA, or PNA back...
Figure 10: Examples of fluorescent PNA nucleobases. R1 denotes DNA, RNA, or PNA backbones.
Figure 11: Endosomal entrapment and escape pathways of PNA and PNA conjugates.
Figure 12: (A) representative cell-penetrating peptides (CPPs), (B) conjugation designs and linker chemistries....
Figure 13: Proposed delivery mode by pHLIP-PNA conjugates (A) the transmembrane section of pHLIP interacting w...
Figure 14: Structures of modified penetratin CPP conjugates with PNA linked through either disulfide (for stud...
Figure 15: Chemical structure of C9–PNA, a stable amphipathic (cyclic-peptide)–PNA conjugate.
Figure 16: Structures of PNA conjugates with a lipophilic triphenylphosphonium cation (TPP–PNA) through (A) th...
Figure 17: Structures of (A) chloesteryl–PNA, (B) cholate–PNA and (C) cholate–PNA(cholate)3.
Figure 18: Structures of PNA–GalNAc conjugates (A) (GalNAc)2K, (B) triantennary (GalNAc)3, and (C) trivalent (...
Figure 19: Vitamin B12–PNA conjugates with different linkages.
Figure 20: Structures of (A) neomycin B, (B) PNA–neamine conjugate, and (C) PNA–neosamine conjugate.
Figure 21: PNA clamp (red) binding to target DNA containing a mixture of sequences (A) PNA binds with higher a...
Figure 22: Rolling circle amplification using PNA openers (red) to invade a dsDNA target forming a P-loop. A p...
Figure 23: Molecular beacons containing generic fluorophores (Fl) and quenchers (Q) recognizing a complementar...
Figure 24: (A) Light-up fluorophores such as thiazole orange display fluorescence enhancement upon binding to ...
Figure 25: Templated fluorogenic detection of oligonucleotides using two PNAs. (A) Templated FRET depends on h...
Figure 26: Lateral flow devices use a streptavidin labeled strip on nitrocellulose paper to anchor a capture P...
Beilstein J. Org. Chem. 2021, 17, 1565–1590, doi:10.3762/bjoc.17.112
Graphical Abstract
Figure 1: Some examples of natural products and drugs containing quaternary carbon centers.
Scheme 1: Simplified mechanism for olefin hydrofunctionalization using an electrophilic transition metal as a...
Scheme 2: Selected examples of quaternary carbon centers formed by the intramolecular hydroalkylation of β-di...
Scheme 3: Control experiments and the proposed mechanism for the Pd(II)-catalyzed intermolecular hydroalkylat...
Scheme 4: Intermolecular olefin hydroalkylation of less reactive ketones under Pd(II) catalysis using HCl as ...
Scheme 5: A) Selected examples of Pd(II)-mediated quaternary carbon center synthesis by intermolecular hydroa...
Scheme 6: Selected examples of quaternary carbon center synthesis by gold(III) catalysis. This is the first r...
Scheme 7: Selected examples of inter- (A) and intramolecular (B) olefin hydroalkylations promoted by a silver...
Scheme 8: A) Intermolecular hydroalkylation of N-alkenyl β-ketoamides under Au(I) catalysis in the synthesis ...
Scheme 9: Asymmetric pyrrolidine synthesis through intramolecular hydroalkylation of α-substituted N-alkenyl ...
Scheme 10: Proposed mechanism for the chiral gold(I) complex promotion of the intermolecular olefin hydroalkyl...
Scheme 11: Selected examples of carbon quaternary center synthesis by gold and evidence of catalytic system pa...
Scheme 12: Synthesis of a spiro compound via an aza-Michael addition/olefin hydroalkylation cascade promoted b...
Scheme 13: A selected example of quaternary carbon center synthesis using an Fe(III) salt as a catalyst for th...
Scheme 14: Intermolecular hydroalkylation catalyzed by a cationic iridium complex (Fuji (2019) [47]).
Scheme 15: Generic example of an olefin hydrofunctionalization via MHAT (Shenvi (2016) [51]).
Scheme 16: The first examples of olefin hydrofunctionalization run under neutral conditions (Mukaiyama (1989) [56]...
Scheme 17: A) Aryl olefin dimerization catalyzed by vitamin B12 and triggered by HAT. B) Control experiment to...
Scheme 18: Generic example of MHAT diolefin cycloisomerization and possible competitive pathways. Shenvi (2014...
Scheme 19: Selected examples of the MHAT-promoted cycloisomerization reaction of unactivated olefins leading t...
Scheme 20: Regioselective carbocyclizations promoted by an MHAT process (Norton (2008) [76]).
Scheme 21: Selected examples of quaternary carbon centers synthetized via intra- (A) and intermolecular (B) MH...
Scheme 22: A) Proposed mechanism for the Fe(III)/PhSiH3-promoted radical conjugate addition between olefins an...
Scheme 23: Examples of cascade reactions triggered by HAT for the construction of trans-decalin backbone uniti...
Scheme 24: A) Selected examples of the MHAT-promoted radical conjugate addition between olefins and p-quinone ...
Scheme 25: A) MHAT triggered radical conjugate addition/E1cB/lactonization (in some cases) cascade between ole...
Scheme 26: A) Spirocyclization promoted by Fe(III) hydroalkylation of unactivated olefins. B) Simplified mecha...
Scheme 27: A) Selected examples of the construction of a carbon quaternary center by the MHAT-triggered radica...
Scheme 28: Hydromethylation of unactivated olefins under iron-mediated MHAT (Baran (2015) [95]).
Scheme 29: The hydroalkylation of unactivated olefins via iron-mediated reductive coupling with hydrazones (Br...
Scheme 30: Selected examples of the Co(II)-catalyzed bicyclization of dialkenylarenes through the olefin hydro...
Scheme 31: Proposed mechanism for the bicyclization of dialkenylarenes triggered by a MHAT process (Vanderwal ...
Scheme 32: Enantioconvergent cross-coupling between olefins and tertiary halides (Fu (2018) [108]).
Scheme 33: Proposed mechanism for the Ni-catalyzed cross-coupling reaction between olefins and tertiary halide...
Scheme 34: Proposed catalytic cycles for a MHAT/Ni cross-coupling reaction between olefins and halides (Shenvi...
Scheme 35: Selected examples of the hydroalkylation of olefins by a dual catalytic Mn/Ni system (Shenvi (2019) ...
Scheme 36: A) Selected examples of quaternary carbon center synthesis by reductive atom transfer; TBC: 4-tert-...
Scheme 37: A) Selected examples of quaternary carbon centers synthetized by radical addition to unactivated ol...
Scheme 38: A) Selected examples of organophotocatalysis-mediated radical polyene cyclization via a PET process...
Scheme 39: A) Sc(OTf)3-mediated carbocyclization approach for the synthesis of vicinal quaternary carbon cente...
Scheme 40: Scope of the Lewis acid-catalyzed methallylation of electron-rich styrenes. Method A: B(C6F5)3 (5.0...
Scheme 41: The proposed mechanism for styrene methallylation (Oestreich (2019) [123]).
Beilstein J. Org. Chem. 2021, 17, 1323–1334, doi:10.3762/bjoc.17.92
Graphical Abstract
Scheme 1: Schematic overview of g-CN-embedded hydrogel fabrication and its subsequent photoinduced post-modif...
Scheme 2: Hydrophobic hydrogel via photoinduced surface modification over embedded g-CN nanosheets in hydroge...
Figure 1: a) FTIR spectra of freeze-dried HGCM-vTA, HGCM and HG. b) UV spectra of freeze-dried HGCM-vTA, HGCM...
Figure 2: Scanning electron microscopy (SEM) images of a) HGCM and b) HGCM-vTA in combination with their elem...
Figure 3: a) Equilibrium swelling ratios of HG, HGCM, HGCM-vTA at specified time intervals. b) Thermogravimet...
Scheme 3: Overview of pore substructuring via photoinduced free radical polymerization over embedded g-CN nan...
Figure 4: FTIR spectra of freeze-dried HGCM-PAA, HGCM-PAAM, HGCM-PEGMEMA in comparison with HGCM.
Figure 5: Scanning electron microscopy (SEM) images of a) HGCM-PAA, b) HGCM-PAAM, and c) HGCM-PEGMEMA.
Figure 6: a) Thermogravimetric analysis of HGCM, HGCM-PAA, HGCM-PAAM and HGCM-PEGMEMA. b) Equilibrium swellin...
Beilstein J. Org. Chem. 2021, 17, 866–872, doi:10.3762/bjoc.17.72
Graphical Abstract
Scheme 1: Radical addition of Ph2PPPh2 and Ph2P(X)PPh2 to unsaturated C–C bonds.
Scheme 2: The addition of Ph2P(O)PPh2 (1) to 1-octyne (2a).
Scheme 3: Phosphinylphosphination of various terminal alkynes 2 with 1. aIsolated yields. V-40 = 1,1’-azobis(...
Scheme 4: Attempted radical addition to internal alkynes and insight into the addition to 2n.
Scheme 5: A plausible reaction pathway for the radical addition of Ph2P(O)PPh2 to terminal alkynes.
Beilstein J. Org. Chem. 2021, 17, 819–865, doi:10.3762/bjoc.17.71
Graphical Abstract
Figure 1: Marketed drugs with acridine moiety.
Scheme 1: Synthesis of 4-arylacridinediones.
Scheme 2: Proposed mechanism for acridinedione synthesis.
Scheme 3: Synthesis of tetrahydrodibenzoacridinones.
Scheme 4: Synthesis of naphthoacridines.
Scheme 5: Plausible mechanism for naphthoacridines.
Figure 2: Benzoazepines based potent molecules.
Scheme 6: Synthesis of azepinone.
Scheme 7: Proposed mechanism for azepinone formation.
Scheme 8: Synthesis of benzoazulenen-1-one derivatives.
Scheme 9: Proposed mechanism for benzoazulene-1-one synthesis.
Figure 3: Indole-containing pharmacologically active molecules.
Scheme 10: Synthesis of functionalized indoles.
Scheme 11: Plausible mechanism for the synthesis of functionalized indoles.
Scheme 12: Synthesis of spirooxindoles.
Scheme 13: Synthesis of substituted spirooxindoles.
Scheme 14: Plausible mechanism for the synthesis of substituted spirooxindoles.
Scheme 15: Synthesis of pyrrolidinyl spirooxindoles.
Scheme 16: Proposed mechanism for pyrrolidinyl spirooxindoles.
Figure 4: Pyran-containing biologically active molecules.
Scheme 17: Synthesis of functionalized benzopyrans.
Scheme 18: Plausible mechanism for synthesis of benzopyran.
Scheme 19: Synthesis of indoline-spiro-fused pyran derivatives.
Scheme 20: Proposed mechanism for indoline-spiro-fused pyran.
Scheme 21: Synthesis of substituted naphthopyrans.
Figure 5: Marketed drugs with pyrrole ring.
Scheme 22: Synthesis of tetra-substituted pyrroles.
Scheme 23: Mechanism for silica-supported PPA-SiO2-catalyzed pyrrole synthesis.
Scheme 24: Synthesis of pyrrolo[1,10]-phenanthrolines.
Scheme 25: Proposed mechanism for pyrrolo[1,10]-phenanthrolines.
Figure 6: Marketed drugs and molecules containing pyrimidine and pyrimidinones skeletons.
Scheme 26: MWA-MCR pyrimidinone synthesis.
Scheme 27: Two proposed mechanisms for pyrimidinone synthesis.
Scheme 28: MWA multicomponent synthesis of dihydropyrimidinones.
Scheme 29: Proposed mechanism for dihydropyrimidinones.
Figure 7: Biologically active fused pyrimidines.
Scheme 30: MWA- MCR for the synthesis of pyrrolo[2,3-d]pyrimidines.
Scheme 31: Proposed mechanism for pyrrolo[2,3-d]pyrimidines.
Scheme 32: Synthesis of substituted pyrrolo[2,3-d]pyrimidine-2,4-diones.
Scheme 33: Probable pathway for pyrrolo[2,3-d]pyrimidine-2,4-diones.
Scheme 34: Synthesis of pyridopyrimidines.
Scheme 35: Plausible mechanism for the synthesis of pyridopyrimidines.
Scheme 36: Synthesis of dihydropyridopyrimidine and dihydropyrazolopyridine.
Scheme 37: Proposed mechanism for the formation of dihydropyridopyrimidine.
Scheme 38: Synthesis of thiopyrano[4,3-d]pyrimidines.
Scheme 39: Plausible mechanism for the synthesis of thiopyrano[4,3-d]pyrimidines.
Scheme 40: Synthesis of decorated imidazopyrimidines.
Scheme 41: Proposed mechanism for imidazopyrimidine synthesis.
Figure 8: Pharmacologically active molecules containing purine bases.
Scheme 42: Synthesis of aza-adenines.
Scheme 43: Synthesis of 5-aza-7-deazapurines.
Scheme 44: Proposed mechanism for deazapurines synthesis.
Figure 9: Biologically active molecules containing pyridine moiety.
Scheme 45: Synthesis of steroidal pyridines.
Scheme 46: Proposed mechanism for steroidal pyridine.
Scheme 47: Synthesis of N-alkylated 2-pyridones.
Scheme 48: Two possible mechanisms for pyridone synthesis.
Scheme 49: Synthesis of pyridone derivatives.
Scheme 50: Postulated mechanism for synthesis of pyridone.
Figure 10: Biologically active fused pyridines.
Scheme 51: Benzimidazole-imidazo[1,2-a]pyridines synthesis.
Scheme 52: Mechanism for the synthesis of benzimidazole-imidazo[1,2-a]pyridines.
Scheme 53: Synthesis of pyrazolo[3,4-b]pyridine-5-spirocycloalkanedione derivatives.
Scheme 54: Proposed mechanism for spiro-pyridines.
Scheme 55: Functionalized macrocyclane-fused pyrazolo[3,4-b]pyridine derivatives.
Scheme 56: Mechanism postulated for macrocyclane-fused pyrazolo[3,4-b]pyridine.
Scheme 57: Generation of pyrazolo[3,4-b]pyridines.
Scheme 58: Proposed mechanism for the synthesis of pyrazolo[3,4-b]pyridines.
Scheme 59: Proposed mechanism for the synthesis of azepinoindole.
Figure 11: Pharmaceutically important molecules with quinoline moiety.
Scheme 60: Povarov-mediated quinoline synthesis.
Scheme 61: Proposed mechanism for Povarov reaction.
Scheme 62: Synthesis of pyrazoloquinoline.
Scheme 63: Plausible mechanism for pyrazoloquinoline synthesis.
Figure 12: Quinazolinones as pharmacologically significant scaffolds.
Scheme 64: Four-component reaction for dihydroquinazolinone.
Scheme 65: Proposed mechanism for dihydroquinazolinones.
Scheme 66: Synthesis purine quinazolinone and PI3K-δ inhibitor.
Scheme 67: Synthesis of fused benzothiazolo/benzoimidazoloquinazolinones.
Scheme 68: Proposed mechanism for fused benzothiazolo/benzoimidazoloquinazolinones.
Scheme 69: On-water reaction for synthesis of thiazoloquinazolinone.
Scheme 70: Proposed mechanism for the thiazoloquinazolinone synthesis.
Scheme 71: β-Cyclodextrin-mediated synthesis of indoloquinazolinediones.
Scheme 72: Proposed mechanism for synthesis of indoloquinazolinediones.
Figure 13: Triazoles-containing marketted drugs and pharmacologically active molecules.
Scheme 73: Cu(I) DAPTA-catalyzed 1,2,3-triazole formation.
Scheme 74: Mechanism for Cu(I) DAPTA-catalyzed triazole formation.
Scheme 75: Synthesis of β-hydroxy-1,2,3-triazole.
Scheme 76: Proposed mechanism for synthesis of β-hydroxy-1,2,3-triazoles.
Scheme 77: Synthesis of bis-1,2,4-triazoles.
Scheme 78: Proposed mechanism for bis-1,2,4-triazoles synthesis.
Figure 14: Thiazole containing drugs.
Scheme 79: Synthesis of a substituted thiazole ring.
Scheme 80: Synthesis of pyrazolothiazoles.
Figure 15: Chromene containing drugs.
Scheme 81: Magnetic nanocatalyst-mediated aminochromene synthesis.
Scheme 82: Proposed mechanism for the synthesis of chromenes.
Beilstein J. Org. Chem. 2021, 17, 711–718, doi:10.3762/bjoc.17.60
Graphical Abstract
Scheme 1: Synthesis of intermediate 1. Reagents and conditions: (i) trifluoroacetic anhydride, CH2Cl2, 0–35 °...
Scheme 2: Synthesis of intermediate 2. Reagents and conditions: (i) Pd/C (wet), EtOAc/CH2Cl2, H2, 45 psi, rt,...
Scheme 3: Synthesis of intermediates 3–5. Reagents and conditions: (i) (Ac)2O, CH2Cl2, rt, 24 h, 95–99%; (ii)...
Scheme 4: Synthesis of compounds A1–21. Reagents and conditions: (i) acetyl chloride, TEA, CH2Cl2, rt, 16 h, ...
Scheme 5: Synthesis of compounds A22 and A23. Reagents and conditions: (i) HATU, DIPEA or DCC, DMAP, DMF or T...
Beilstein J. Org. Chem. 2021, 17, 1–10, doi:10.3762/bjoc.17.1
Graphical Abstract
Figure 1: Different methodologies employed to study PPIs. The protein used for illustration is the heterodime...
Figure 2: Mechanisms of homooligomeric complex formations. a) Domain swapping of RNase A (PDB: 1A2W) [73]. The sw...
Figure 3: Parts a) and b) represent the electron densities and B-factors of TMV, respectively. The cryo-EM st...
Figure 4: Schematic of the general assembly of charged protein containers to form binary nanoparticle superla...
Beilstein J. Org. Chem. 2020, 16, 3069–3077, doi:10.3762/bjoc.16.256
Graphical Abstract
Scheme 1: Dolbier’s protocol for the SF5Cl radical addition on alkenes.
Scheme 2: Proposed mechanism for the amine–borane complex-initiated radical addition of SF5Cl on alkenes.
Figure 1: Structures and acronyms of the amine-borane complexes investigated.
Scheme 3: Scope of the Et3B and the DICAB-initiated SF5Cl additions on alkenes. Unless noted otherwise, isola...
Scheme 4: Scope of the Et3B and the DICAB-initiated SF5Cl additions on alkynes. Unless noted otherwise, isola...
Beilstein J. Org. Chem. 2020, 16, 2757–2768, doi:10.3762/bjoc.16.226
Graphical Abstract
Scheme 1: RCEYM with Ru and Mo catalysts.
Scheme 2: Beneficial effect of ethene atmosphere.
Scheme 3: Enantioselective dienyne metathesis [21].
Scheme 4: Diastereoselective endiyne metathesis [31].
Figure 1: Oxaenediynes considered for the study of desymmetrizing RCEYM.
Scheme 5: Synthesis of hepta-1,6-diyn-4-ol (4a).
Scheme 6: Protection of hepta-1,6-diyn-4-ol (4a).
Scheme 7: Alkylation of the protected diynols 7a and 8a.
Scheme 8: Deprotection of protected diynols 7b, 7c and 8b–d.
Scheme 9: Synthesis of the oxaenediynes 2 and 9 bearing an allyl or a methallyl group.
Scheme 10: Synthesis of oxaenediynes 2e and 2f bearing ester or silyl groups.
Scheme 11: Synthesis of alkadiynyl acrylates 10 and methacrylates 11.
Figure 2: The ruthenium precatalysts employed.
Scheme 12: RCEYM of oxaenediynes 2.
Figure 3: Examples of side products of CM with ethene.
Scheme 13: Attempted RCEYM of oxaenediynes 9, alkadiynyl acrylates 10 and methacrylates 11.
Scheme 14: Diels–Alder reaction of dihydropyran 12b with N-phenylmaleimide (13).
Figure 4: The four possible diastereoisomers of hexahydropyranoisoindole 14.
Figure 5: Conformations of dihydropyran 12b.
Figure 6: The two most stable s-trans (left) and s-cis (right) conformations of dihydropyran 12b.
Figure 7: The two most stable transition states endo-trans 15B and exo-cis 15C (hydrogens are omitted for cla...
Figure 8: PES of the Diels–Alder reaction of dihydropyran 12b and maleimide 13.
Beilstein J. Org. Chem. 2020, 16, 2363–2441, doi:10.3762/bjoc.16.197
Graphical Abstract
Scheme 1: Amine/photoredox-catalysed α-alkylation of aldehydes with alkyl bromides bearing electron-withdrawi...
Scheme 2: Amine/HAT/photoredox-catalysed α-functionalisation of aldehydes using alkenes.
Scheme 3: Amine/cobalt/photoredox-catalysed α-functionalisation of ketones and THIQs.
Scheme 4: Amine/photoredox-catalysed α-functionalisation of aldehydes or ketones with imines. (a) Using keton...
Scheme 5: Bifunctional amine/photoredox-catalysed enantioselective α-functionalisation of aldehydes.
Scheme 6: Bifunctional amine/photoredox-catalysed α-functionalisation of aldehydes using amine catalysts via ...
Scheme 7: Amine/photoredox-catalysed RCA of iminium ion intermediates. (a) Synthesis of quaternary stereocent...
Scheme 8: Bifunctional amine/photoredox-catalysed RCA of enones in a radical chain reaction initiated by an i...
Scheme 9: Bifunctional amine/photoredox-catalysed RCA reactions of iminium ions with different radical precur...
Scheme 10: Bifunctional amine/photoredox-catalysed radical cascade reactions between enones and alkenes with a...
Scheme 11: Amine/photocatalysed photocycloadditions of iminium ion intermediates. (a) External photocatalyst u...
Scheme 12: Amine/photoredox-catalysed addition of acrolein (94) to iminium ions.
Scheme 13: Dual NHC/photoredox-catalysed acylation of THIQs.
Scheme 14: NHC/photocatalysed spirocyclisation via photoisomerisation of an extended Breslow intermediate.
Scheme 15: CPA/photoredox-catalysed aza-pinacol cyclisation.
Scheme 16: CPA/photoredox-catalysed Minisci-type reaction between azaarenes and α-amino radicals.
Scheme 17: CPA/photoredox-catalysed radical additions to azaarenes. (a) α-Amino radical or ketyl radical addit...
Scheme 18: CPA/photoredox-catalysed reduction of azaarene-derived substrates. (a) Reduction of ketones. (b) Ex...
Scheme 19: CPA/photoredox-catalysed radical coupling reactions of α-amino radicals with α-carbonyl radicals. (...
Scheme 20: CPA/photoredox-catalysed Povarov reaction.
Scheme 21: CPA/photoredox-catalysed reactions with imines. (a) Decarboxylative imine generation followed by Po...
Scheme 22: Bifunctional CPA/photocatalysed [2 + 2] photocycloadditions.
Scheme 23: PTC/photocatalysed oxygenation of 1-indanone-derived β-keto esters.
Scheme 24: PTC/photoredox-catalysed perfluoroalkylation of 1-indanone-derived β-keto esters via a radical chai...
Scheme 25: Bifunctional hydrogen bonding/photocatalysed intramolecular [2 + 2] photocycloadditions of quinolon...
Scheme 26: Bifunctional hydrogen bonding/photocatalysed intramolecular RCA cyclisation of a quinolone.
Scheme 27: Bifunctional hydrogen bonding/photocatalysed intramolecular [2 + 2] photocycloadditions of quinolon...
Scheme 28: Bifunctional hydrogen bonding/photocatalysed [2 + 2] photocycloaddition reactions. (a) First use of...
Scheme 29: Bifunctional hydrogen bonding/photocatalysed deracemisation of allenes.
Scheme 30: Bifunctional hydrogen bonding/photocatalysed deracemisation reactions. (a) Deracemisation of sulfox...
Scheme 31: Bifunctional hydrogen bonding/photocatalysed intramolecular [2 + 2] photocycloaddition of coumarins....
Scheme 32: Bifunctional hydrogen bonding/photocatalysed [2 + 2] photocycloadditions of quinolones. (a) Intramo...
Scheme 33: Hydrogen bonding/photocatalysed formal arylation of benzofuranones.
Scheme 34: Hydrogen bonding/photoredox-catalysed dehalogenative protonation of α,α-chlorofluoro ketones.
Scheme 35: Hydrogen bonding/photoredox-catalysed reductions. (a) Reduction of 1,2-diketones. (b) Reduction of ...
Scheme 36: Hydrogen bonding/HAT/photocatalysed deracemisation of cyclic ureas.
Scheme 37: Hydrogen bonding/HAT/photoredox-catalysed synthesis of cyclic sulfonamides.
Scheme 38: Hydrogen bonding/photoredox-catalysed reaction between imines and indoles.
Scheme 39: Chiral cation/photoredox-catalysed radical coupling of two α-amino radicals.
Scheme 40: Chiral phosphate/photoredox-catalysed hydroetherfication of alkenols.
Scheme 41: Chiral phosphate/photoredox-catalysed synthesis of pyrroloindolines.
Scheme 42: Chiral anion/photoredox-catalysed radical cation Diels–Alder reaction.
Scheme 43: Lewis acid/photoredox-catalysed cycloadditions of carbonyls. (a) Formal [2 + 2] cycloaddition of en...
Scheme 44: Lewis acid/photoredox-catalysed RCA reaction using a scandium Lewis acid between α-amino radicals a...
Scheme 45: Lewis acid/photoredox-catalysed RCA reaction using a copper Lewis acid between α-amino radicals and...
Scheme 46: Lewis acid/photoredox-catalysed synthesis of 1,2-amino alcohols from aldehydes and nitrones using a...
Scheme 47: Lewis acid/photocatalysed [2 + 2] photocycloadditions of enones and alkenes.
Scheme 48: Meggers’s chiral-at-metal catalysts.
Scheme 49: Lewis acid/photoredox-catalysed α-functionalisation of ketones with alkyl bromides bearing electron...
Scheme 50: Bifunctional Lewis acid/photoredox-catalysed radical coupling reaction using α-chloroketones and α-...
Scheme 51: Lewis acid/photocatalysed RCA of enones. (a) Using aldehydes as acyl radical precursors. (b) Other ...
Scheme 52: Bifunctional Lewis acid/photocatalysis for a photocycloaddition of enones.
Scheme 53: Lewis acid/photoredox-catalysed RCA reactions of enones using DHPs as radical precursors.
Scheme 54: Lewis acid/photoredox-catalysed functionalisation of β-ketoesters. (a) Hydroxylation reaction catal...
Scheme 55: Bifunctional copper-photocatalysed alkylation of imines.
Scheme 56: Copper/photocatalysed alkylation of imines. (a) Bifunctional copper catalysis using α-silyl amines....
Scheme 57: Bifunctional Lewis acid/photocatalysed intramolecular [2 + 2] photocycloaddition.
Scheme 58: Bifunctional Lewis acid/photocatalysed [2 + 2] photocycloadditions (a) Intramolecular cycloaddition...
Scheme 59: Bifunctional Lewis acid/photocatalysed rearrangement of 2,4-dieneones.
Scheme 60: Lewis acid/photocatalysed [2 + 2] cycloadditions of cinnamate esters and styrenes.
Scheme 61: Nickel/photoredox-catalysed arylation of α-amino acids using aryl bromides.
Scheme 62: Nickel/photoredox catalysis. (a) Desymmetrisation of cyclic meso-anhydrides using benzyl trifluorob...
Scheme 63: Nickel/photoredox catalysis for the acyl-carbamoylation of alkenes with aldehydes using TBADT as a ...
Scheme 64: Bifunctional copper/photoredox-catalysed C–N coupling between α-chloro amides and carbazoles or ind...
Scheme 65: Bifunctional copper/photoredox-catalysed difunctionalisation of alkenes with alkynes and alkyl or a...
Scheme 66: Copper/photoredox-catalysed decarboxylative cyanation of benzyl phthalimide esters.
Scheme 67: Copper/photoredox-catalysed cyanation reactions using TMSCN. (a) Propargylic cyanation (b) Ring ope...
Scheme 68: Palladium/photoredox-catalysed allylic alkylation reactions. (a) Using alkyl DHPs as radical precur...
Scheme 69: Manganese/photoredox-catalysed epoxidation of terminal alkenes.
Scheme 70: Chromium/photoredox-catalysed allylation of aldehydes.
Scheme 71: Enzyme/photoredox-catalysed dehalogenation of halolactones.
Scheme 72: Enzyme/photoredox-catalysed dehalogenative cyclisation.
Scheme 73: Enzyme/photoredox-catalysed reduction of cyclic imines.
Scheme 74: Enzyme/photocatalysed enantioselective reduction of electron-deficient alkenes as mixtures of (E)/(Z...
Scheme 75: Enzyme/photoredox catalysis. (a) Deacetoxylation of cyclic ketones. (b) Reduction of heteroaromatic...
Scheme 76: Enzyme/photoredox-catalysed synthesis of indole-3-ones from 2-arylindoles.
Scheme 77: Enzyme/HAT/photoredox catalysis for the DKR of primary amines.
Scheme 78: Bifunctional enzyme/photoredox-catalysed benzylic C–H hydroxylation of trifluoromethylated arenes.
Beilstein J. Org. Chem. 2020, 16, 2151–2192, doi:10.3762/bjoc.16.183
Graphical Abstract
Figure 1: Fluorine-containing drugs.
Figure 2: Fluorinated agrochemicals.
Scheme 1: Selectivity of fluorination reactions.
Scheme 2: Different mechanisms of photocatalytic activation. Sub = substrate.
Figure 3: Jablonski diagram showing visible-light-induced energy transfer pathways: a) absorption, b) IC, c) ...
Figure 4: Schematic illustration of TTET.
Figure 5: Organic triplet PSCats.
Figure 6: Additional organic triplet PSCats.
Figure 7: A) Further organic triplet PSCats and B) transition metal triplet PSCats.
Figure 8: Different fluorination reagents grouped by generation.
Scheme 3: Synthesis of Selectfluor®.
Scheme 4: General mechanism of PS TTET C(sp3)–H fluorination.
Scheme 5: Selective benzylic mono- and difluorination using 9-fluorenone and xanthone PSCats, respectively.
Scheme 6: Chen’s photosensitized monofluorination: reaction scope.
Scheme 7: Chen’s photosensitized benzylic difluorination reaction scope.
Scheme 8: Photosensitized monofluorination of ethylbenzene on a gram scale.
Scheme 9: Substrate scope of Tan’s AQN-photosensitized C(sp3)–H fluorination.
Scheme 10: AQN-photosensitized C–H fluorination reaction on a gram scale.
Scheme 11: Reaction mechanism of the AQN-assisted fluorination.
Figure 9: 3D structures of the singlet ground and triplet excited states of Selectfluor®.
Scheme 12: Associated transitions for the activation of acetophenone by violet light.
Scheme 13: Ethylbenzene C–H fluorination with various PSCats and conditions.
Scheme 14: Effect of different PSCats on the C(sp3)–H fluorination of cyclohexane (39).
Scheme 15: Reaction scope of Chen’s acetophenone-photosensitized C(sp3)–H fluorination reaction.
Figure 10: a) Site-selectivity of Chen’s acetophenone-photosensitized C–H fluorination reaction [201]. b) Site-sele...
Scheme 16: Formation of the AQN–Selectfluor® exciplex Int1.
Scheme 17: Generation of the C3 2° pentane radical and the Selectfluor® N-radical cation from the exciplex.
Scheme 18: Hydrogen atom abstraction by the Selectfluor® N-radical cation from pentane to give the C3 2° penta...
Scheme 19: Fluorine atom transfer from Selectfluor® to the C3 2° pentane radical to yield 3-fluoropentane and ...
Scheme 20: Barrierless fluorine atom transfer from Int1 to the C3 2° pentane radical to yield 3-fluoropentane,...
Scheme 21: Ketone-directed C(sp3)–H fluorination.
Scheme 22: Ketone-directed fluorination through a 5- and a 6-membered transition state, respectively.
Scheme 23: Effect of different PSCats on the photosensitized C(sp3)–H fluorination of 47.
Scheme 24: Substrate scope of benzil-photoassisted C(sp3)–H fluorinations.
Scheme 25: A) Benzil-photoassisted enone-directed C(sp3)–H fluorination. B) Classification of the reaction mod...
Scheme 26: A) Xanthone-photoassisted ketal-directed C(sp3)–H fluorination. B) Substrate scope. C) C–H fluorina...
Scheme 27: Rationale for the selective HAT at the C2 C–H bond of galactose acetonide.
Scheme 28: Photosensitized C(sp3)–H benzylic fluorination of a peptide using different PSCats.
Scheme 29: Peptide scope of 5-benzosuberenone-photoassisted C(sp3)–H fluorinations.
Scheme 30: Continuous flow PS TTET monofluorination of 72.
Scheme 31: Photosensitized C–H fluorination of N-butylphthalimide as a PSX.
Scheme 32: Substrate scope and limitations of the PSX C(sp3)–H monofluorination.
Scheme 33: Substrate crossover monofluorination experiment.
Scheme 34: PS TTET mechanism proposed by Hamashima and co-workers.
Scheme 35: Photosensitized TFM of 78 to afford α-trifluoromethylated ketone 80.
Scheme 36: Substrate scope for photosensitized styrene TFM to give α-trifluoromethylated ketones.
Scheme 37: Control reactions for photosensitized TFM of styrenes.
Scheme 38: Reaction mechanism for photosensitized TFM of styrenes to afford α-trifluoromethylated ketones.
Scheme 39: Reaction conditions for TFMs to yield the cis- and the trans-product, respectively.
Scheme 40: Substrate scope of trifluoromethylated (E)-styrenes.
Scheme 41: Strategies toward trifluoromethylated (Z)-styrenes.
Scheme 42: Substrate scope of trifluoromethylated (Z)-styrenes.
Scheme 43: Reaction mechanism for photosensitized TFM of styrenes to afford E- or Z-products.
Beilstein J. Org. Chem. 2020, 16, 1924–1935, doi:10.3762/bjoc.16.159
Graphical Abstract
Scheme 1: Synthesis of NHC-supported catalysts.
Scheme 2: Negishi benchmark reaction.
Figure 1: Negishi reaction catalyzed by immobilized NHC–Pd complexes. Conditions: methyl 4-bromobenzoate (0.2...
Scheme 3: Synthesis of immobilized NHC–Pd–RuPhos.
Figure 2: Negishi model reaction between 5 and 6 under flow conditions catalyzed by 4b. V = 0.535 mL, 363 mg ...
Figure 3: Negishi model reaction under flow conditions catalyzed by 8a. V = 2.9 mL, 1.25 g of catalyst, resid...
Figure 4: Negishi reaction between 5 and 6 catalyzed by 8a in the presence of SILLPs. a) Yield (%) vs time fo...
Figure 5: TEM images of the polymers after the Negishi reaction between 5 and 6. a) 8a, bar scale 20 nm, PdNP...
Scheme 4: Pd species immobilized onto SILLPs. i) 1 g SILLP 10, 100 mg PdCl2 in milli-Q® water (100 mL 1% HCl,...
Figure 6: Negishi reaction between 5 and 6 catalyzed by 11. 1 equiv methyl 4-bromobenzoate (6, 0.25 mmol), 2 ...
Figure 7: Negishi reaction between 5 and 6 under flow conditions catalyzed by 8a in the presence of a scaveng...
Figure 8: Effect of the structure of the SILLP scavenger for the Negishi reaction between 5 and 6 under flow ...
Figure 9: TEM images of the polymer after the Negishi reaction between 5 and 6 under flow conditions. a) 8a + ...
Beilstein J. Org. Chem. 2020, 16, 833–857, doi:10.3762/bjoc.16.76
Graphical Abstract
Scheme 1: Norrish type I and II dissociations.
Scheme 2: Proposed radical pair formation after the photolysis of benzaldehyde (8).
Scheme 3: Aldehydes in the Paterno–Büchi reaction.
Scheme 4: 2,3-Diazabicyclo[2.2.1]hept-2-ene (DBH).
Scheme 5: Dissociation pathways of benzaldehyde.
Scheme 6: Reactions that lead to polarized products detectable by CIDNP.
Scheme 7: MMA (26), DEABP (27), and Michler’s ketone (28).
Scheme 8: Radical intermediates of DEABP.
Scheme 9: Photoinitiated polymerization of monomeric MMA (26) using the quinoxalines 32 and benzaldehyde (8).
Scheme 10: Acetone (4) and formaldehyde (35) as photografting initiators.
Scheme 11: Photografting by employing acetaldehyde (36) as the photoinitiator.
Scheme 12: Proposed photolysis mechanism for aliphatic ketones 44 and formaldehyde (35).
Scheme 13: Initiator 50, reductant 51, and benzaldehyde derivatives 52–54 for the polymerization of the methac...
Scheme 14: Proposed mechanism of the photomediated atom transfer radical polymerization employing the benzalde...
Scheme 15: cis/trans isomerization employing triplet states of photosensitizers.
Scheme 16: Salicylaldehyde (68) forms an internal hydrogen bond.
Scheme 17: Olefin isomerization via energy transfer from a carbonyl compound.
Scheme 18: Mechanistic pathways for the Paterno–Büchi reaction.
Scheme 19: Isomeric oxetanes formed after photochemical addition of aryl aldehydes to 2-butenes.
Scheme 20: Rotation of the C3–C4 bond of the biradical intermediate may lead to all four conformations.
Scheme 21: Photolysis products of benzaldehyde (8) in different solvents. a) In benzene or ethanol. b) In hex-...
Scheme 22: N-tert-Butylbenzamide formation proceeds via a benzoyl radical.
Scheme 23: Photochemical pinacol coupling.
Scheme 24: Photochemical ATRA catalyzed by 4-anisaldehyde (52).
Scheme 25: Proposed triplet sensitization mechanism of the ATRA reaction in the presence of 4-anisaldehyde (52...
Scheme 26: Benzaldehyde-mediated photoredox CDC reaction: compatible amides and ethers.
Scheme 27: Photoredox cross-dehydrogenative coupling (CDC) conditions and proposed reaction mechanism.
Scheme 28: Optimized conditions for the photoredox merger reaction.
Scheme 29: Proposed mechanism for the C(sp3)–H alkylation/arylation of ethers.
Scheme 30: Substrate scope for the photochemical alkylation of ethers.
Scheme 31: C(sp3)–H Functionalization of N-containing molecules.
Scheme 32: Substrate scope for the photochemical alkylation of N-containing molecules.
Scheme 33: Additional products yielded by the photochemical alkylation reaction of N-containing molecules.
Scheme 34: C(sp3)–H functionalization of thioethers.
Scheme 35: Proposed mechanism for the C(sp3)–H alkylation/arylation of N-containing molecules and thioethers.
Scheme 36: Hydroacylation using 4-cyanobenzaldehyde (53) as the photoinitiator.
Scheme 37: Selectivity for the formation of the α,α-disubstituted aldehydes.
Scheme 38: Substrate scope for the photochemical addition of aldehydes to Michael acceptors.
Scheme 39: Proposed mechanism for the hydroacylation of Michael acceptors using 4-cyanobenzaldehyde (53) as th...
Scheme 40: Catalytic arylation of aromatic aldehydes by aryl bromides in which the reaction product acts as th...
Scheme 41: Proposed mechanism for the catalytic arylation of benzaldehydes by aryl bromides in which the react...
Scheme 42: Functionalization of the chiral cyclobutanes 180.
Scheme 43: Optimized reaction conditions and proposed mechanism for the sulfonylcyanation of cyclobutenes.
Beilstein J. Org. Chem. 2020, 16, 415–444, doi:10.3762/bjoc.16.40
Graphical Abstract
Scheme 1: Structural patterns of several symmetric cyanines relating to trimethines (I), pentamethines (II), ...
Scheme 2: 1-Substituted 2,3,3-trimethylindolium-, 2,3,3-benzo[e]indolium-, and 2,3,3-benzo[c,d]indolium salts...
Scheme 3: Substitution of the chlorine substituent at the meso-position by a stronger nucleophilic moiety B [68].
Scheme 4: Structure of alternative chain builders for synthesis of heptamethines.
Figure 1: Simplified process chart of photophysical processes occurring in NIR absorbers.
Scheme 5: Chemical structure of the electron acceptors that were from iodonium cations 88 and triazines 89.
Figure 2: Photoinduced electron transfer under different scenarios in which each example exhibits an intrinsi...
Scheme 6: Photoexcited absorber 33 results in reaction with an iodonium cation in the respective cation radic...
Scheme 7: Reaction scheme of absorbers comprising in the molecules center a five ring bridged moiety. This le...
Scheme 8: Structure of donor compounds used in a three component system.
Figure 3: Cationic photopolymerization of an epoxide (Epikote 828) initiated by excitation of the absorber 36...
Scheme 9: Different modes of photoinitiated ATRP using UV, visible and NIR light.
Scheme 10: The structure of Sens used in photo-ATRP.
Figure 4: Comparison of the GPC traces of precursor PMMA with a) chain extended PMMA and b) PMMA-b-PS. Condit...
Figure 5: Spectral changes of the solution of 48 in the presence of [Cu(L)]Br2 (L: tris(2-pyridylmethyl)amine...
Scheme 11: Photoinduced CuAAC reactions in which photochemical reactions result in formation of the Cu(I) cata...
Scheme 12: Model reaction between benzyl azide and phenyacetylene using the absorber 48 as NIR sensitizer at 7...
Figure 6: Block copolymerization of the precursors PS-N3 and Alkyne-PCL results in the block copolymer PS-b-P...
Figure 7: UV–vis–NIR absorption changes of the solution of 48 in the presence of PMDETA, phenylacetylene and ...
Scheme 13: Workflow to design and process new materials in a setup based on an intelligent DoE to develop tech...
Scheme 14: Illustration of the iDoE setting up experiments suggested and analyzed by the A.I. After defining t...
Scheme 15: Classification of the factors for the formation of polymer networks by NIR-photocuring depending on...
Beilstein J. Org. Chem. 2019, 15, 2043–2051, doi:10.3762/bjoc.15.201
Graphical Abstract
Scheme 1: Synthesis of reference NDI 1 and cNDIs 2–6; bottom: image of saturated solutions of cNDIs 2–6 in DM...
Figure 1: Optical properties of NDI 1 and cNDIs 2 and 6: UV–vis absorbance in CH2Cl2 and in DMF (normal lines...
Scheme 2: Photocatalytic α-alkylation of octanal (12): 500 mM 12, 250 mM 13, 50 mM (20 mol %) organocatalyst ...
Figure 2: Normalized absorbance of cNDI 6 in comparison to normalized emission of the 468 nm, 520 nm, 597 nm,...
Figure 3: Kinetic analysis of yields of product 14 in the presence (solid lines) and in the absence (dashed l...
Beilstein J. Org. Chem. 2019, 15, 1612–1704, doi:10.3762/bjoc.15.165
Graphical Abstract
Figure 1: Various drugs having IP nucleus.
Figure 2: Participation percentage of various TMs for the syntheses of IPs.
Scheme 1: CuI–NaHSO4·SiO2-catalyzed synthesis of imidazo[1,2-a]pyridines.
Scheme 2: Experimental examination of reaction conditions.
Scheme 3: One-pot tandem reaction for the synthesis of 2-haloimidazopyridines.
Scheme 4: Mechanistic scheme for the synthesis of 2-haloimidazopyridine.
Scheme 5: Copper-MOF-catalyzed three-component reaction (3-CR) for imidazo[1,2-a]pyridines.
Scheme 6: Mechanism for copper-MOF-driven synthesis.
Scheme 7: Heterogeneous synthesis via titania-supported CuCl2.
Scheme 8: Mechanism involving oxidative C–H functionalization.
Scheme 9: Heterogeneous synthesis of IPs.
Scheme 10: One-pot regiospecific synthesis of imidazo[1,2-a]pyridines.
Scheme 11: Vinyl azide as an unprecedented substrate for imidazo[1,2-a]pyridines.
Scheme 12: Radical pathway.
Scheme 13: Cu(I)-catalyzed transannulation approach for imidazo[1,5-a]pyridines.
Scheme 14: Plausible radical pathway for the synthesis of imidazo[1,5-a]pyridines.
Scheme 15: A solvent-free domino reaction for imidazo[1,2-a]pyridines.
Scheme 16: Cu-NPs-mediated synthesis of imidazo[1,2-a]pyridines.
Scheme 17: CuI-catalyzed synthesis of isoxazolylimidazo[1,2-a]pyridines.
Scheme 18: Functionalization of 4-bromo derivative via Sonogashira coupling reaction.
Scheme 19: A plausible reaction pathway.
Scheme 20: Cu(I)-catalyzed intramolecular oxidative C–H amidation reaction.
Scheme 21: One-pot synthetic reaction for imidazo[1,2-a]pyridine.
Scheme 22: Plausible reaction mechanism.
Scheme 23: Cu(OAc)2-promoted synthesis of imidazo[1,2-a]pyridines.
Scheme 24: Mechanism for aminomethylation/cycloisomerization of propiolates with imines.
Scheme 25: Three-component synthesis of imidazo[1,2-a]pyridines.
Figure 3: Scope of pyridin-2(1H)-ones and acetophenones.
Scheme 26: CuO NPS-promoted A3 coupling reaction.
Scheme 27: Cu(II)-catalyzed C–N bond formation reaction.
Scheme 28: Mechanism involving Chan–Lam/Ullmann coupling.
Scheme 29: Synthesis of formyl-substituted imidazo[1,2-a]pyridines.
Scheme 30: A tandem sp3 C–H amination reaction.
Scheme 31: Probable mechanistic approach.
Scheme 32: Dual catalytic system for imidazo[1,2-a]pyridines.
Scheme 33: Tentative mechanism.
Scheme 34: CuO/CuAl2O4/ᴅ-glucose-promoted 3-CCR.
Scheme 35: A tandem CuOx/OMS-2-based synthetic strategy.
Figure 4: Biomimetic catalytic oxidation in the presence of electron-transfer mediators (ETMs).
Scheme 36: Control experiment.
Scheme 37: Copper-catalyzed C(sp3)–H aminatin reaction.
Scheme 38: Reaction of secondary amines.
Scheme 39: Probable mechanistic pathway.
Scheme 40: Coupling reaction of α-azidoketones.
Scheme 41: Probable pathway.
Scheme 42: Probable mechanism with free energy calculations.
Scheme 43: MCR for cyanated IP synthesis.
Scheme 44: Substrate scope for the reaction.
Scheme 45: Reaction mechanism.
Scheme 46: Probable mechanistic pathway for Cu/ZnAl2O4-catalyzed reaction.
Scheme 47: Copper-catalyzed double oxidative C–H amination reaction.
Scheme 48: Application towards different coupling reactions.
Scheme 49: Reaction mechanism.
Scheme 50: Condensation–cyclization approach for the synthesis of 1,3-diarylated imidazo[1,5-a]pyridines.
Scheme 51: Optimized reaction conditions.
Scheme 52: One-pot 2-CR.
Scheme 53: One-pot 3-CR without the isolation of chalcone.
Scheme 54: Copper–Pybox-catalyzed cyclization reaction.
Scheme 55: Mechanistic pathway catalyzed by Cu–Pybox complex.
Scheme 56: Cu(II)-promoted C(sp3)-H amination reaction.
Scheme 57: Wider substrate applicability for the reaction.
Scheme 58: Plausible reaction mechanism.
Scheme 59: CuI assisted C–N cross-coupling reaction.
Scheme 60: Probable reaction mechanism involving sp3 C–H amination.
Scheme 61: One-pot MCR-catalyzed by CoFe2O4/CNT-Cu.
Scheme 62: Mechanistic pathway.
Scheme 63: Synthetic scheme for 3-nitroimidazo[1,2-a]pyridines.
Scheme 64: Plausible mechanism for CuBr-catalyzed reaction.
Scheme 65: Regioselective synthesis of halo-substituted imidazo[1,2-a]pyridines.
Scheme 66: Synthesis of 2-phenylimidazo[1,2-a]pyridines.
Scheme 67: Synthesis of diarylated compounds.
Scheme 68: CuBr2-mediated one-pot two-component oxidative coupling reaction.
Scheme 69: Decarboxylative cyclization route to synthesize 1,3-diarylimidazo[1,5-a]pyridines.
Scheme 70: Mechanistic pathway.
Scheme 71: C–H functionalization reaction of enamines to produce diversified heterocycles.
Scheme 72: A plausible mechanism.
Scheme 73: CuI-promoted aerobic oxidative cyclization reaction of ketoxime acetates and pyridines.
Scheme 74: CuI-catalyzed pathway for the formation of imidazo[1,2-a]pyridine.
Scheme 75: Mechanistic pathway.
Scheme 76: Mechanistic rationale for the synthesis of products.
Scheme 77: Copper-catalyzed synthesis of vinyloxy-IP.
Scheme 78: Regioselective product formation with propiolates.
Scheme 79: Proposed mechanism for vinyloxy-IP formation.
Scheme 80: Regioselective synthesis of 3-hetero-substituted imidazo[1,2-a]pyridines with different reaction su...
Scheme 81: Mechanistic pathway.
Scheme 82: CuI-mediated synthesis of 3-formylimidazo[1,2-a]pyridines.
Scheme 83: Radical pathway for 3-formylated IP synthesis.
Scheme 84: Pd-catalyzed urea-cyclization reaction for IPs.
Scheme 85: Pd-catalyzed one-pot-tandem amination and intramolecular amidation reaction.
Figure 5: Scope of aniline nucleophiles.
Scheme 86: Pd–Cu-catalyzed Sonogashira coupling reaction.
Scheme 87: One-pot amide coupling reaction for the synthesis of imidazo[4,5-b]pyridines.
Scheme 88: Urea cyclization reaction for the synthesis of two series of pyridines.
Scheme 89: Amidation reaction for the synthesis of imidazo[4,5-b]pyridines.
Figure 6: Amide scope.
Scheme 90: Pd NPs-catalyzed 3-component reaction for the synthesis of 2,3-diarylated IPs.
Scheme 91: Plausible mechanistic pathway for Pd NPs-catalyzed MCR.
Scheme 92: Synthesis of chromenoannulated imidazo[1,2-a]pyridines.
Scheme 93: Mechanism for the synthesis of chromeno-annulated IPs.
Scheme 94: Zinc oxide NRs-catalyzed synthesis of imidazo[1,2-a]azines/diazines.
Scheme 95: Zinc oxide-catalyzed isocyanide based GBB reaction.
Scheme 96: Reaction pathway for ZnO-catalyzed GBB reaction.
Scheme 97: Mechanistic pathway.
Scheme 98: ZnO NRs-catalyzed MCR for the synthesis of imidazo[1,2-a]azines.
Scheme 99: Ugi type GBB three-component reaction.
Scheme 100: Magnetic NPs-catalyzed synthesis of imidazo[1,2-a]pyridines.
Scheme 101: Regioselective synthesis of 2-alkoxyimidazo[1,2-a]pyridines catalyzed by Fe-SBA-15.
Scheme 102: Plausible mechanistic pathway for the synthesis of 2-alkoxyimidazopyridine.
Scheme 103: Iron-catalyzed synthetic approach.
Scheme 104: Iron-catalyzed aminooxygenation reaction.
Scheme 105: Mechanistic pathway.
Scheme 106: Rh(III)-catalyzed double C–H activation of 2-substituted imidazoles and alkynes.
Scheme 107: Plausible reaction mechanism.
Scheme 108: Rh(III)-catalyzed non-aromatic C(sp2)–H bond activation–functionalization for the synthesis of imid...
Scheme 109: Reactivity and selectivity of different substrates.
Scheme 110: Rh-catalyzed direct C–H alkynylation by Li et al.
Scheme 111: Suggested radical mechanism.
Scheme 112: Scandium(III)triflate-catalyzed one-pot reaction and its mechanism for the synthesis of benzimidazo...
Scheme 113: RuCl3-assisted Ugi-type Groebke–Blackburn condensation reaction.
Scheme 114: C-3 aroylation via Ru-catalyzed two-component reaction.
Scheme 115: Regioselective synthetic mechanism.
Scheme 116: La(III)-catalyzed one-pot GBB reaction.
Scheme 117: Mechanistic approach for the synthesis of imidazo[1,2-a]pyridines.
Scheme 118: Synthesis of imidazo[1,2-a]pyridine using LaMnO3 NPs under neat conditions.
Scheme 119: Mechanistic approach.
Scheme 120: One-pot 3-CR for regioselective synthesis of 2-alkoxy-3-arylimidazo[1,2-a]pyridines.
Scheme 121: Formation of two possible products under optimization of the catalysts.
Scheme 122: Mechanistic strategy for NiFe2O4-catalyzed reaction.
Scheme 123: Two-component reaction for synthesizing imidazodipyridiniums.
Scheme 124: Mechanistic scheme for the synthesis of imidazodipyridiniums.
Scheme 125: CuI-catalyzed arylation of imidazo[1,2-a]pyridines.
Scheme 126: Mechanism for arylation reaction.
Scheme 127: Cupric acetate-catalyzed double carbonylation approach.
Scheme 128: Radical mechanism for double carbonylation of IP.
Scheme 129: C–S bond formation reaction catalyzed by cupric acetate.
Scheme 130: Cupric acetate-catalyzed C-3 formylation approach.
Scheme 131: Control experiments for signifying the role of DMSO and oxygen.
Scheme 132: Mechanism pathway.
Scheme 133: Copper bromide-catalyzed CDC reaction.
Scheme 134: Extension of the substrate scope.
Scheme 135: Plausible radical pathway.
Scheme 136: Transannulation reaction for the synthesis of imidazo[1,5-a]pyridines.
Scheme 137: Plausible reaction pathway for denitrogenative transannulation.
Scheme 138: Cupric acetate-catalyzed C-3 carbonylation reaction.
Scheme 139: Plausible mechanism for regioselective C-3 carbonylation.
Scheme 140: Alkynylation reaction at C-2 of 3H-imidazo[4,5-b]pyridines.
Scheme 141: Two-way mechanism for C-2 alkynylation of 3H-imidazo[4,5-b]pyridines.
Scheme 142: Palladium-catalyzed SCCR approach.
Scheme 143: Palladium-catalyzed Suzuki coupling reaction.
Scheme 144: Reaction mechanism.
Scheme 145: A phosphine free palladium-catalyzed synthesis of C-3 arylated imidazopyridines.
Scheme 146: Palladium-mediated Buchwald–Hartwig cross-coupling reaction.
Figure 7: Structure of the ligands optimized.
Scheme 147: Palladium acetate-catalyzed direct arylation of imidazo[1,2-a]pyridines.
Scheme 148: Palladium acetate-catalyzed mechanistic pathway.
Scheme 149: Palladium acetate-catalyzed regioselective arylation reported by Liu and Zhan.
Scheme 150: Mechanism for selective C-3 arylation of IP.
Scheme 151: Pd(II)-catalyzed alkenylation reaction with styrenes.
Scheme 152: Pd(II)-catalyzed alkenylation reaction with acrylates.
Scheme 153: A two way mechanism.
Scheme 154: Double C–H activation reaction catalyzed by Pd(OAc)2.
Scheme 155: Probable mechanism.
Scheme 156: Palladium-catalyzed decarboxylative coupling.
Scheme 157: Mechanistic cycle for decarboxylative arylation reaction.
Scheme 158: Ligand-free approach for arylation of imidazo[1,2-a]pyridine-3-carboxylic acids.
Scheme 159: Mechanism for ligandless arylation reaction.
Scheme 160: NHC-Pd(II) complex assisted arylation reaction.
Scheme 161: C-3 arylation of imidazo[1,2-a]pyridines with aryl bromides catalyzed by Pd(OAc)2.
Scheme 162: Pd(II)-catalyzed C-3 arylations with aryl tosylates and mesylates.
Scheme 163: CDC reaction for the synthesis of imidazo[1,2-a]pyridines.
Scheme 164: Plausible reaction mechanism for Pd(OAc)2-catalyzed synthesis of imidazo[1,2-a]pyridines.
Scheme 165: Pd-catalyzed C–H amination reaction.
Scheme 166: Mechanism for C–H amination reaction.
Scheme 167: One-pot synthesis for 3,6-di- or 2,3,6-tri(hetero)arylimidazo[1,2-a]pyridines.
Scheme 168: C–H/C–H cross-coupling reaction of IPs and azoles catalyzed by Pd(II).
Scheme 169: Mechanistic cycle.
Scheme 170: Rh-catalyzed C–H arylation reaction.
Scheme 171: Mechanistic pathway for C–H arylation of imidazo[1,2-a]pyridine.
Scheme 172: Rh(III)-catalyzed double C–H activation of 2-phenylimidazo[1,2-a]pyridines and alkynes.
Scheme 173: Rh(III)-catalyzed mechanistic pathway.
Scheme 174: Rh(III)-mediated oxidative coupling reaction.
Scheme 175: Reactions showing functionalization of the product obtained by the group of Kotla.
Scheme 176: Mechanism for Rh(III)-catalyzed oxidative coupling reaction.
Scheme 177: Rh(III)-catalyzed C–H activation reaction.
Scheme 178: Mechanistic cycle.
Scheme 179: Annulation reactions of 2-arylimidazo[1,2-a]pyridines and alkynes.
Scheme 180: Two-way reaction mechanism for annulations reaction.
Scheme 181: [RuCl2(p-cymene)]2-catalyzed C–C bond formation reaction.
Scheme 182: Reported reaction mechanism.
Scheme 183: Fe(III) catalyzed C-3 formylation approach.
Scheme 184: SET mechanism-catalyzed by Fe(III).
Scheme 185: Ni(dpp)Cl2-catalyzed KTC coupling.
Scheme 186: Pd-catalyzed SM coupling.
Scheme 187: Vanadium-catalyzed coupling of IP and NMO.
Scheme 188: Mechanistic cycle.
Scheme 189: Selective C3/C5–H bond functionalizations by mono and bimetallic systems.
Scheme 190: rGO-Ni@Pd-catalyzed C–H bond arylation of imidazo[1,2-a]pyridine.
Scheme 191: Mechanistic pathway for heterogeneously catalyzed arylation reaction.
Scheme 192: Zinc triflate-catalyzed coupling reaction of substituted propargyl alcohols.
Beilstein J. Org. Chem. 2019, 15, 963–970, doi:10.3762/bjoc.15.93
Graphical Abstract
Scheme 1: Fast trimethylene carbonate polymerization using a solvent-free ball-milling approach.
Figure 1: IR thermometer images showing reactor temperatures at the end of the two individual ball-milling re...
Beilstein J. Org. Chem. 2019, 15, 733–745, doi:10.3762/bjoc.15.69
Graphical Abstract
Figure 1: Absorption spectra in the UV and visible spectral region: 1) bis(cyclopentadienyl)titan dichloride (...
Figure 2: Absorption spectra in the visible spectral region: 1) Cp2TiCl2·AlEt2Cl (toluene, 10 mmol/L, Ti/Al r...
Figure 3: 1Н NMR spectra of tricyclopentadiene (a) and the interaction product between Cp2TiCl2 and AlEt2Cl w...
Scheme 1: Mechanism of alkylation of Cp2TiCl2.
Figure 4: Visible spectra of a mixture of Cp2TiCl2 and AlEt2Cl as function of time.
Figure 5: Thermometric curve of DCPD polymerization using the catalyst system based on Cp2TiCl2 (a) and its s...
Scheme 2: The structures formed as a result of the cationic polymerization of dicyclopentadiene.
Scheme 3: The units resulting from ROMP of dicyclopentadiene.
Scheme 4: Mechanism of ROMP dicyclopentadiene.
Figure 6: FTIR spectrum of PDCPD obtained in toluene with the catalyst system based on Cp2TiCl2 and AlEt2Cl.
Figure 7: 1Н NMR spectrum of PDCPD obtained with the catalytic system based on Cp2TiCl2 and AlEt2Cl.
Figure 8: GPC traces for two samples of DCPD polymers obtained at a concentration of Cp2TiCl2/AlEt2Cl complex...
Figure 9: IR spectra of cationic polymerized dicyclopentadiene taken after certain periods of time exposed to...
Figure 10: Correlation of intensities of vibrational bands at 1620 and 700 cm−1 and layer exposure time in air...
Figure 11: DSC exotherm for PDCPD subjected to air oxidation for 700 hours.
Figure 12: DSC exotherm for PDCPD subjected to unexposed film: 1) in air atmosphere; 2) in argon.
Scheme 5: Possible radical formation in the reaction (1).
Scheme 6: The first step of the chain propagation.
Figure 13: Dependence of intensities of adsorption bands at 1410 and 700 cm−1 and dwell time of the layer in a...
Figure 14: Semi-logarithmic kinetic curve of PDCPD oxidation in air (thin layer on silicon) with respect to in...
Figure 15: The distribution of oxygen concentration in the polymer layer: 1 – a layer of oxidized cross-linked...
Figure 16: Dependence of the ratio of adsorption bands at 1700 and 700 cm−1 on the exposure time of the layer ...
Figure 17: Infrared spectra (a) of products of cationic polymerization of DCPD, stabilized with an antioxidant...
Beilstein J. Org. Chem. 2019, 15, 445–468, doi:10.3762/bjoc.15.39
Graphical Abstract
Scheme 1: Most common metathesis reactions. Ring-opening metathesis polymerization (ROMP), acyclic diene meta...
Scheme 2: Catalytic cycle for metathesis proposed by Chauvin.
Figure 1: Some of the most representative catalysts for aqueous metathesis. a) Well-defined ruthenium catalys...
Scheme 3: First aqueous ROMP reactions catalyzed by ruthenium(III) salts.
Scheme 4: Degradation pathway of first generation Grubbs catalyst (G-I) in methanol.
Scheme 5: Synthesis of Blechert-type catalysts 19 and 20.
Figure 2: Chemical structure and components of amphiphilic molecule PTS and derivatives.
Scheme 6: RCM of selected substrates in the presence of the surfactant PTS. Conditionsa: The reaction was car...
Scheme 7: RCM reactions of substrates 31 and 33 with the encapsulated G-II catalyst.
Scheme 8: Living ROMP of norbornene derivatives 35 and 36 with phosphine-based catalysts bearing quaternary a...
Scheme 9: Synthesis of water-soluble catalysts 3 and 4 bearing quaternary ammonium tags.
Scheme 10: In situ formation of catalyst 5 bearing a quaternary ammonium group.
Scheme 11: Catalyst recycling of an ammonium-bearing catalyst.
Scheme 12: Removal of the water-soluble catalyst 12 through host–guest interaction with silica-gel-supported β...
Scheme 13: Selection of artificial metathases reported by Ward and co-workers (ArM 1 based on biotin–(strept)a...
Figure 3: In vivo metathesis with an artificial metalloenzyme based on the biotin–streptavidin technology.
Scheme 14: Artificial metathase based on covalent anchoring approach. α-Chymotrypsin interacts with catalyst 66...
Scheme 15: Assembling an artificial metathase (ArM 4) based on the small heat shock protein from M. Jannaschii...
Scheme 16: Artificial metathases based on cavity-size engineered β-barrel protein nitrobindin (NB4exp). The HG...
Scheme 17: Artificial metathase based on cutinase (ArM 8) and resulting metathesis activities.
Scheme 18: Site-specific modification of proteins via aqueous cross-metathesis. The protein structure is based...
Scheme 19: a) Allyl homocysteine (Ahc)-modified proteins as CM substrates. b) Incorporation of Ahc in the Fc p...
Scheme 20: On-DNA cross-metathesis reaction of allyl sulfide 99.
Scheme 21: Preparation of BODIPY-containing profluorescent probes 102 and 104.
Scheme 22: Metathesis-based ethylene detection in live cells.
Scheme 23: First example of stapled peptides via olefin metathesis.
Beilstein J. Org. Chem. 2019, 15, 194–209, doi:10.3762/bjoc.15.19
Graphical Abstract
Figure 1: Structures of Grubbs 1 (1) and 2 (2) precatalysts.
Scheme 1: Design concepts for ruthenium alkylidene precatalysts [3].
Figure 2: Structures of Grubbs 1-type (3) and 2-type (4) pyridinyl-alcoholato precatalysts.
Figure 3: Structures of Grubbs 2-type (5) pyridinyl-alcoholato precatalysts.
Figure 4: Structures of pyridinyl-substituted Grubbs 2-type pyridinyl-alcoholato precatalysts.
Figure 5: The influence of the reaction temperature on the (a) conversion of 1-octene, (b) formation of PMPs ...
Figure 6: The influence of the reaction temperature on the (a) conversion of 1-octene, (b) formation of PMPs ...
Figure 7: The influence of the reaction temperature on the (a) conversion of 1-octene, (b) formation of PMPs ...
Figure 8: The influence of the reaction temperature on the (a) conversion of 1-octene, (b) formation of PMPs ...
Figure 9: Geometry-optimised structures of precatalyst 9, 6 and 8.
Figure 10: An illustration of the envisaged methoxy oxygen lone pair-aromatic π-electron interaction.
Figure 11: Influence of precatalysts 6–9 and 5d on the (a) conversion of 1-octene and (b) ln([n%1-octene]) ver...
Figure 12: 1H NMR spectra of the carbene-Hα region at different time intervals of the 1-octene/7 reaction mixt...
Figure 13: 1H NMR spectra of the Hα region of the pyridine ring of the 1-octene/7 reaction mixture in toluene-d...
Scheme 2: Synthesis of pyridinyl-alcohol ligands and Grubbs 2-type pyridinyl-alcoholato complexes.
Beilstein J. Org. Chem. 2019, 15, 160–166, doi:10.3762/bjoc.15.16
Graphical Abstract
Figure 1: Structures of the Ru-based catalysts used in this study.
Beilstein J. Org. Chem. 2019, 15, 30–43, doi:10.3762/bjoc.15.3
Graphical Abstract
Figure 1: Charge-tagged L-proline-derived catalyst 1∙Cl [18].
Scheme 1: Putative catalytic cycle [51] for the L-proline-catalyzed Diels–Alder reaction with inverse electron de...
Scheme 2: Synthesis of the charge-tagged tetrazine 4∙Br as a reactant for the proline-catalyzed Diels–Alder r...
Scheme 3: Reaction R1: L-proline-catalyzed reaction between 2 and acetone.
Figure 2: NMR monitoring of reaction R1 in deuterated DMSO (concentration of tetrazine 0.005 mmol/mL).
Scheme 4: Equilibrium of oxazolidinone and enamine formation.
Figure 3: a) ESI mass spectrum of reaction R1 after 26 min. b) ESIMS monitoring of reaction R1. To better vis...
Figure 4: ESI mass spectrum of reaction R1 with preformed I1 8 minutes after adding substrate 2.
Scheme 5: Reaction R2: L-proline-catalyzed reaction between charge-tagged substrate 4∙Br and acetone. The reg...
Figure 5: ESI mass spectrum of reaction R2 using a continuous-flow setup with a calculated reaction time of 8...
Figure 6: a) Reaction R2 after two hours (syringe setup). b) ESIMS monitoring of reaction R2. Signal intensit...
Scheme 6: Reaction R3: substrate 2, acetone and charge-tagged catalyst 1∙Cl.
Figure 7: ESI mass spectrum of reaction R3 at 60 °C after 1.5 h.
Scheme 7: General catalytic cycle for reactions R1–R3.
Figure 8: ESIMS monitoring of reaction R3. The plotted intensity values for each molecule are a sum of all co...
Figure 9: Isomeric forms in equilibrium: enamine [I3a]+, oxazolidinone [I3b]+ and iminium [I3c]+.
Figure 10: ESI(+) CID spectrum of mass-selected [I3]+ (m/z 353); collision energy voltage 1 V.
Figure 11: ESI(+) CID spectrum of mass selected [II3]+ (m/z 589); collision energy voltage 5 V.
Figure 12: ESI(+) CID spectrum of mass selected [III3]+ (m/z 561); collision energy voltage 10 V.
Beilstein J. Org. Chem. 2018, 14, 3122–3149, doi:10.3762/bjoc.14.292
Graphical Abstract
Figure 1: Second-generation Grubbs (GII), Hoveyda (HGII), Grela (Gre-II), Blechert (Ble-II) and indenylidene-...
Figure 2: Grubbs (1a) and Hoveyda-type (1b) complexes with N-phenyl, N’-mesityl NHCs.
Figure 3: C–H insertion product 2.
Figure 4: Grubbs (3a–6a) and Hoveyda-type (3b–6b) complexes with N-fluorophenyl, N’-aryl NHCs.
Scheme 1: RCM of diethyl diallylmalonate (7).
Scheme 2: RCM of diethyl allylmethallylmalonate (9).
Scheme 3: RCM of diethyl dimethallylmalonate (11).
Scheme 4: CM of allylbenzene (13) with cis-1,4-diacetoxy-2-butene (14).
Scheme 5: ROMP of 1,5-cyclooctadiene (16).
Figure 5: Grubbs (18a–21a) and Hoveyda-type (18b–21b) catalysts bearing uNHCs with a hexafluoroisopropylalkox...
Figure 6: A Grubbs-type complex with an N-adamantyl, N’-mesityl NHC 22 and the Hoveyda-type complex with a ch...
Figure 7: Grubbs (24a and 25a) and Hoveyda-type (24b and 25b) complexes with N-alkyl, N’-mesityl NHCs.
Figure 8: Grubbs-type complexes 31–34 with N-alkyl, N’-mesityl NHCs.
Figure 9: Grubbs-type complex 35 with an N-cyclohexyl, N’-2,6-diisopropylphenyl NHC.
Figure 10: Hoveyda-type complexes with an N-alkyl, N’-mesityl (36, 37) and an N-alkyl, N’-2,6-diisopropylpheny...
Figure 11: Indenylidene-type complexes 41–43 with N-alkyl, N’-mesityl NHCs.
Figure 12: Grubbs-type complex 44 and its monopyridine derivative 45 containing a chiral uNHC.
Scheme 6: Alternating copolymerization of 46 with 47 and 48.
Figure 13: Pyridine-containing complexes 49–52 and Grubbs-type complex 53.
Figure 14: Hoveyda-type complexes 54–58 in the alternating ROMP of NBE (46) and COE (47).
Figure 15: Catalysts 59 and 60 in the tandem RO–RCM of 47.
Figure 16: Hoveyda-type complexes 61–69 with N-alkyl, N’-aryl NHCs.
Scheme 7: Ethenolysis of methyl oleate (70).
Scheme 8: AROCM of cis-5-norbornene-endo-2,3-dicarboxylic anhydride (75) with styrene.
Figure 17: Hoveyda-type catalysts 79–82 with N-tert-butyl, N’-aryl NHCs.
Scheme 9: Latent ROMP of 83 with catalyst 82.
Figure 18: Indenylidene and Hoveyda-type complexes 85–92 with N-cycloalkyl, N’-mesityl NHCs.
Scheme 10: RCM of N,N-dimethallyl-N-tosylamide (93) with catalyst 85.
Scheme 11: Self metathesis of 13 with catalyst 85.
Figure 19: Grubbs-type complexes 98–104 with N-alkyl, N’-mesityl NHCs.
Figure 20: Grubbs-type complexes 105–115 with N-alkyl, N’-mesityl ligands.
Figure 21: Complexes 116 and 117 bearing a carbohydrate-based NHC.
Figure 22: Complexes 118 and 119 bearing a hemilabile amino-tethered NHC.
Figure 23: Indenylidene-type complexes 120–126 with N-benzyl, N’-mesityl NHCs.
Scheme 12: Diastereoselective ring-rearrangement metathesis (dRRM) of cyclopentene 131.
Figure 24: Indenylidene-type complexes 134 and 135 with N-nitrobenzyl, N’-mesityl NHCs.
Figure 25: Hoveyda-type complexes 136–138 with N-benzyl, N’-mesityl NHCs.
Figure 26: Hoveyda-type complexes 139–142 with N-benzyl, N’-Dipp NHC.
Figure 27: Indenylidene (143–146) and Hoveyda-type (147) complexes with N-heteroarylmethyl, N’-mesityl NHCs.
Figure 28: Hoveyda-type complexes 148 and 149 with N-phenylpyrrole, N’-mesityl NHCs.
Figure 29: Grubbs-type complexes with N-trifluoromethyl benzimidazolidene NHCs 150–153, 155 and N-isopropyl be...
Scheme 13: Ethenolysis of ethyl oleate 156.
Scheme 14: Ethenolysis of cis-cyclooctene (47).
Figure 30: Grubbs-type C1-symmetric (164) and C2-symmetric (165) catalysts with a backbone-substituted NHC.
Figure 31: Possible syn and anti rotational isomers of catalyst 164.
Scheme 15: ARCM of substrates 166, 168 and 170.
Figure 32: Hoveyda (172) and Grubbs-type (173,174) backbone-substituted C1-symmetric NHC complexes.
Scheme 16: ARCM of 175,177 and 179 with catalyst 174.
Figure 33: Grubbs-type C1-symmetric NHC catalysts bearing N-propyl (181, 182) or N-benzyl (183, 184) groups on...
Scheme 17: ARCM of 185 and 187 promoted by 184 to form the encumbered alkenes 186 and 188.
Figure 34: N-Alkyl, N’-isopropylphenyl NHC ruthenium complexes with syn (189, 191) and anti (190, 192) phenyl ...
Figure 35: Hoveyda-type complexes 193–198 bearing N-alkyl, N’-aryl backbone-substituted NHC ligands.
Scheme 18: ARCM of 166 and 199 promoted by 192b.
Figure 36: Enantiopure catalysts 201a and 201b with syn phenyl units on the NHC backbone.
Figure 37: Backbone-monosubstituted catalysts 202–204.
Figure 38: Grubbs (205a) and Hoveyda-type (205b) backbone-monosubstituted catalysts.
Scheme 19: AROCM of 206 with allyltrimethylsilane promoted by catalyst 205a.
Beilstein J. Org. Chem. 2018, 14, 3047–3058, doi:10.3762/bjoc.14.283
Graphical Abstract
Scheme 1: Degenerative radical transfer of xanthates to olefins.
Scheme 2: Photocatalytic RAFT polymerization of xanthate 4.
Figure 1: Photoluminescence (PL) spectra of the 3MLCT state of 8 in degassed DMSO solvent with (A) various co...
Figure 2: (A) ns-Transient absorption spectra of photocatalyst 8 in degassed DMSO recorded at different delay...
Figure 3: UV–vis absorption spectrum of 1a (1 mM solution in DMSO).
Scheme 3: Determination of quantum yield.
Scheme 4: Proposed reaction mechanism.
Beilstein J. Org. Chem. 2018, 14, 3025–3046, doi:10.3762/bjoc.14.282
Graphical Abstract
Figure 1: Typical oxidative and reductive cycle for a photoredox catalyst (PC).
Figure 2: Transitions involved in absorbing species containing π, σ and n electrons.
Figure 3: Ligand to metal charge transfer (illustrated here for a d6 metal complex).
Figure 4: Metal to ligand charge transfer (illustrated here for a d5 metal complex).
Scheme 1: Structures of additives involved in the photoredox catalytic cycles.
Figure 5: Catalytic cycles involved with iodonium salt and (A) (TMS)3SiH, (B) NVK and (C) EDB.
Scheme 2: Structures of photoredox metal-based catalysts.
Scheme 3: Photocatalytical cycle for the Ru complex.
Scheme 4: Structures of photoredox organocatalysts.
Scheme 5: Diversity of the chemical structures of photoredox organocatalysts.
Scheme 6: Structures of benchmarked monomers.
Scheme 7: Structure of the CARET additive.
Scheme 8: Photoredox catalysis mechanism of a visible light-mediated living radical polymerization. (Abbrevia...